| __timestamp | Bausch Health Companies Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 242549000 |
| Thursday, January 1, 2015 | 582800000 | 245098000 |
| Friday, January 1, 2016 | 455000000 | 147600000 |
| Sunday, January 1, 2017 | 366000000 | 264600000 |
| Monday, January 1, 2018 | 414000000 | 357900000 |
| Tuesday, January 1, 2019 | 471000000 | 1182600000 |
| Wednesday, January 1, 2020 | 452000000 | 357700000 |
| Friday, January 1, 2021 | 465000000 | 540100000 |
| Saturday, January 1, 2022 | 529000000 | 322900000 |
| Sunday, January 1, 2023 | 604000000 | 408000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Bausch Health Companies Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Bausch Health's R&D expenses have shown a steady increase, peaking at approximately 604 million in 2023, a 145% rise from 2014. Meanwhile, United Therapeutics has exhibited a more volatile pattern, with a significant spike in 2019, reaching nearly 1.18 billion, before stabilizing around 408 million in 2023.
This data highlights the strategic differences between the two companies: Bausch Health's consistent growth versus United Therapeutics' aggressive yet fluctuating investment strategy. As the pharmaceutical industry continues to innovate, these spending patterns may offer insights into future breakthroughs and market leadership.
Zoetis Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Research and Development Investment: Biogen Inc. vs United Therapeutics Corporation
Comparing Innovation Spending: United Therapeutics Corporation and Neurocrine Biosciences, Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Opthea Limited
Research and Development Expenses Breakdown: United Therapeutics Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Amicus Therapeutics, Inc.
R&D Insights: How United Therapeutics Corporation and Taro Pharmaceutical Industries Ltd. Allocate Funds
United Therapeutics Corporation vs Travere Therapeutics, Inc.: Strategic Focus on R&D Spending
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Pharming Group N.V. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Bausch Health Companies Inc.